Copyright
©The Author(s) 2004.
World J Gastroenterol. Dec 15, 2004; 10(24): 3634-3638
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3634
Published online Dec 15, 2004. doi: 10.3748/wjg.v10.i24.3634
Table 4 Treatment-related toxicity
| Adverse event | Grade | Total (%) | |||
| I | II | III | IV | ||
| Fever | 10 | 5 | 1 | 0 | 16 (30.2) |
| Injection site pain | 12 | 2 | 0 | 0 | 14 (26.4) |
| Nausea and vomiting | 13 | 5 | 0 | 0 | 18 (34.0) |
| Leucopenia | 12 | 7 | 3 | 4 | 26 (49.1) |
| Liver dysfunction | 2 | 0 | 0 | 1 | 3 (5.7) |
| Flu-like symptom | 13 | 2 | 0 | 0 | 15 (28.3) |
| Alopecia | 3 | 3 | 1 | 0 | 7 (13.2) |
- Citation: Lu W, Zheng S, Li XF, Huang JJ, Zheng X, Li Z. Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial. World J Gastroenterol 2004; 10(24): 3634-3638
- URL: https://www.wjgnet.com/1007-9327/full/v10/i24/3634.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i24.3634